DNA as a possible target for antitumor ruthenium(III) complexes: A spectroscopic and molecular biology study of the interactions of two representative antineoplastic ruthenium(III) complexes with DNA

Archives of Biochemistry and Biophysics

Volumn 376, Issue 1, 2000, Pages 156-162

  Gallori, Enzo ^a   Vettori, Cristina ^a   Alessio, Enzo ^b   Vilchez, Francisco Gonzalez ^c   Vilaplana, Rosario ^c   Orioli, Pierluigi ^a   Casini, Angela ^a   Messori, Luigi ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Cancer; Circular dichroism; DNA; Electrophoresis; Restriction enzymes; Ruthenium complexes

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DICHLORO (1,2 PROPYLENDIAMINETETRAACETATE)RUTHENIUM; PLASMID DNA; RESTRICTION ENDONUCLEASE; RUTHENIUM COMPLEX; UNCLASSIFIED DRUG;

ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DNA CONFORMATION; DRUG DNA INTERACTION; DRUG MECHANISM; DRUG TARGETING; MOLECULAR DYNAMICS; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; REACTION ANALYSIS;

EID: 0034177718     PISSN: 00039861     EISSN: None     Source Type: Journal    
DOI: 10.1006/abbi.1999.1654     Document Type: Article

References (28)

1. Clarke M. J., Stubbs M. Met. Ions Biol. Syst. 32:1996;727.
2. Keppler B. K., Henn M., Juhl U. M., Berger M. R., Niebl R., Wagner F. F. Prog. Clin. Biochem. Med. 10:1989;41.
3. Hartmann M., Keppler B. K. Comments Inorg. Chem. 16:1995;339.
4. Keppler B. K. Metal Complexes in Cancer Chemotherapy. 1993;VCH, Weinheim.
5. Alessio E., Mestroni G., Sava G., Bergamo A., Coluccia M., Messori L. Hadjiliadis N. D. Cytotoxic, Mutagenic and Carcinogenic Potential of Heavy Metals Related to Human Environment. 1997;Kluwer Academic, Dordrecht, Norwell.
6. Sava G., Pacor S., Coluccia M., Mariggio M., Cocchietto M., Alessio E., Mestroni G. Drug Invest. 8:1994;150.
7. Frasca D., Ciampa J., Emerson J., Umans R. S., Clarke M. J. Met. Based Drugs. 3:1996;197.
8. Novakova O., Kasparova J., Vrana O., van Vliet P. M., Reedijk J., Brabec V. Biochemistry. 34:1995;12369.
9. Barca A., Pani B., Tamaro M., Russo E. Mutat. Res. 423:1999;171.
10. Esposito G., Cauci S., Fogolari F., Alessio E., Scocchi M., Quadrifoglio F., Viglino P. Biochemistry. 31:1992;7094.
11. Sava G., Capozzi I., Bergamo A., Gagliardi R., Cocchietto M., Masiero L., Onisto M., Alessio E., Mestroni G., Garbisa S. Int. J. Cancer. 68:1996;60.
12. Sava G., Pacor S., Bergamo A., Cocchietto M., Mestroni G., Alessio E. Chem. Biol. Interact. 95:1995;109.
13. Sava G., Alessio E., Bergamo A., Mestroni G. Top. Bioinorg. Chem. 1:1999;143.
14. Alessio E., Balducci G., Lutman A., Mestroni G., Calligaris M., Attia W. M. Inorg. Chim. Acta. 203:1993;205.
15. Vilaplana R., Romero M. A., Quiros M., Salas J. M., Gonzalez-Vilchez F. Met. Based Drugs. 2:1995;211.
16. Ehrlich S. D. Proc. Natl. Acad. Sci. USA. 75:1978;1433.
17. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, New York.
18. Messori L., Kratz F., Alessio E. Met. Based Drugs. 3:1996;243.
19. Gonzalez-Vilchez F., Vilaplana R., Blasco G., Messori L. J. Inorg. Biochem. 71:1998;45.
20. Brabec V., Kleinwachter V., Butour J. L., Johnson N. P. Biophys. Chem. 35:1990;129.
21. Cohen G. L., Bauer W. R., Barton J. K., Lippard S. J. Science. 203:1979;1014.
22. Ushay H. M., Tullius T. D., Lippard S. J. Biochemistry. 20:1981;3744.
23. Sherman S. E., Lippard S. J. Chem. Rev. 87:1987;1153.
24. Fox K. Drug-DNA Interact. Protocols. 90:1997;95.
25. Mottes M., Grandi G., Sgaramella V., Canosi U., Morelli G., Trautner T. A. Mol. Gen. Genet. 174:1979;281.
26. Brabec V., Balcarova Z. Eur. J. Biochem. 216:1993;183.
27. Balcarova Z., Mrazek J., Kleinwachter V., Brabec V. Gen. Physiol. Biophys. 11:1992;579.
28. Gelasco A., Lippard S. J. Top. Bioinorg. Chem. 1:1999;3.